Avenue Therapeutics Market Cap

Avenue Therapeutics has a market cap or net worth of $724.82 thousand as of March 9, 2026. Its market cap has decreased by -81.43% in one year.

Market Cap

724.82K

Enterprise Value

-4.24M

Revenue

1.40M

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.27

Market Cap Chart

Since June 27, 2017, Avenue Therapeutics's market cap has decreased from 27.57M to 724.82K, a decrease of -97.37%. That is a compound annual growth rate of -34.19%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	724.82K	-66.53%
Dec 31, 2025	2.17M	-47.28%
Dec 31, 2024	4.11M	92.60%
Dec 29, 2023	2.13M	-61.53%
Dec 30, 2022	5.54M	-70.79%
Dec 31, 2021	18.98M	-80.95%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Lipella Pharmaceuticals	716.69K
SQZ Biotechnologies Company	707.79K
Scorpius Holdings	672.57K
Protagenic Therapeutics	811.84K
EV Biologics	840.53K
Bio-Path Holdings	593.40K
Windtree Therapeutics	578.47K
Altamira Therapeutics	542.97K

Market Cap Rankings